Cluster buy at Orchestra BioMed Holdings, Inc.: four insiders add $230,000 of OBIO
Four insiders reported purchases totalling $230,000 in Form 4 filings. Information only, not investment advice.
Form 4 filings show four Orchestra BioMed Holdings, Inc. insiders buying stock on Nov 9, for a total of $230,000.
David Pacitti (director) made the largest purchase, $100,000 at an average of $5.00 a share. Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan.
Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy. Eric S Fain (director) is the latest to report, in a filing on Nov 9.
Details from the SEC filing:
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Andrew Lawrence Taylor | CFO | Nov 9 | 1,000 | $5.00 | $5,000 | App · SEC |
| David P Hochman | Officer | Nov 9 | 5,000 | $5.00 | $25,000 | App · SEC |
| David Pacitti | Director | Nov 9 | 20,000 | $5.00 | $100,000 | App · SEC |
| Eric S Fain | Director | Nov 9 | 20,000 | $5.00 | $100,000 | App · SEC |
| Total | $230,000 |
See the full OBIO insider activity report
Each row of the table links to its Form 4 on SEC.gov.
Browse the latest insider buying · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.